Research
Mixed
In obese patients with type 2 diabetes and no history of cardiovascular disease, weight loss is associated with reduced all-cause pharmacy costs, diabetes-specific medical costs, and total diabetes-specific healthcare costs.
If you are obese and have type 2 diabetes without heart disease, losing weight can help lower your overall medical bills, including doctor visits and diabetes-specific treatments. This makes weight management a financially beneficial part of your care.
GoodSupportsHIGH confidence
In the subset of patients who were obese and had no previous CVD, weight loss over the 6-month period was also associated with decreased all-cause pharmacy costs, diabetes-specific medical costs, and diabetes-specific total health care costs.
Why this rating
Large observational cohort with multivariable adjustments, specific subgroup analysis.
Source
Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes
Jayanti Mukherjee et al. · Journal of Managed Care & Specialty Pharmacy · 2016
DOI 10.18553/jmcp.2016.22.5.449
cohort · n=1520Cited 11×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →